Botox Related Published Studies
Well-designed clinical trials related to Botox (Botulinum Toxin Type A)
A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy. [2008.09]
A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects. [2008.09]
Upper limb corticomotor projections and physiological changes that occur with botulinum toxin-A therapy in children with hemiplegic cerebral palsy. [2008.08]
Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. [2008.08]
The effect of botulinum toxin type A on full-face intense pulsed light treatment: a randomized, double-blind, split-face study. [2008.08]
Effects of intramural administration of Botulinum Toxin A on gastric emptying and eating capacity in obese patients. [2008.08]
A Double-Blind, Randomized, Placebo-Controlled, Two-Dose Comparative Study of Botulinum Toxin Type A for Treating Glabellar Lines in Japanese Subjects. [2008.07.29]
Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy. [2008.07.08]
Questioning the Need to Use Botox Within 4 Hours of Reconstitution: A Study of Fresh vs 2-Week-Old Botox. [2008.07]
Efficacy and safety of purified botulinum toxin type A (Dysport((R))) for the treatment of benign essential blepharospasm: A randomized, placebo-controlled, phase II trial. [2008.07]
Effect of upper limb botulinum toxin-A therapy on health-related quality of life in children with hemiplegic cerebral palsy. [2008.07]
Refractory idiopathic urge urinary incontinence and botulinum A injection. [2008.07]
Botulinum toxin type a as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. [2008.06]
Can we identify predictors of multilevel botulinum toxin A injections in children with cerebral palsy who walk with a flexed knee pattern? [2008.06]
A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder. [2008.06]
Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia. [2008.05]
Botulinum toxin type A injections into the calf muscles for treatment of spastic equinus in cerebral palsy: a randomized trial comparing single and multiple injection sites. [2008.05]
Shoulder pain and external rotation in spastic hemiplegia do not improve by injection of botulinum toxin A into the subscapular muscle. [2008.05]
[Botulinum toxin A (BTX-A) point injection for treatment of the third lumbar transverse process syndrome] [2008.05]
A dose-response relationship research on botulinum toxin type A local intramuscular injections of lower extremity spasticity in children with cerebral palsy. [2008.05]
Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. [2008.04]
EMLA Cream Application Without Occlusive Dressing Before Upper Facial Botulinum Toxin Injection: A Randomized, Double-Blind, Placebo-Controlled Trial. [2008.04]
Botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: Randomized, double-blind, noninferiority trial. [2008.03.15]
Efficacy and safety of purified botulinum toxin type A (Dysport((R))) for the treatment of benign essential blepharospasm: A randomized, placebo-controlled, phase II trial. [2008.03.04]
Pericranial injection of botulinum toxin type A (Dysport) for tension-type headache - a multicentre, double-blind, randomized, placebo-controlled study. [2008.03]
Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study. [2008.03]
Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia. [2008.03]
Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis. [2008.03]
Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders. [2008.02]
Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse. [2008.02]
Botulinum toxin A for the treatment of delayed gastric emptying. [2008.02]
Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine. [2008.02]
Comparative electrophysiological study of response to botulinum toxin type B in Japanese and Caucasians. [2008.01.30]
Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide. [2008.01]
Botox: shaken, not stirred. [2008.01]
The analgesic effect of botulinum-toxin A on postwhiplash neck pain. [2008.01]
Associated reactions after stroke: a randomized controlled trial of the effect of botulinum toxin type A. [2008.01]
Does botulinum toxin a combined with bracing prevent hip displacement in children with cerebral palsy and "hips at risk"? A randomized, controlled trial. [2008.01]
Therapeutic use of botulinum toxin type a in treating neck and upper-back pain of myofascial origin: a pilot study. [2008.01]
A randomized pilot study comparing the action halos of two commercial preparations of botulinum toxin type A. [2008.01]
Bupivacaine-induced myotoxicity and its effect on botulinum toxin paresis. [2008.01]
Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial. [2008]
A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus. [2007.12]
Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder. [2007.12]
Botulinum Toxin Type A as Migraine Preventive Treatment in Patients Previously Failing Oral Prophylactic Treatment Due To Compliance Issues. [2007.11.28]
Botulinum Toxin Type A in the Treatment of Chronic Migraine Without Medication Overuse. [2007.11.27]
Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. [2007.11.01]
Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy. [2007.11]
Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines. [2007.11]
Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids. [2007.11]
Sensory integration in writer's cramp: comparison with controls and evaluation of botulinum toxin effect. [2007.10]
Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity. [2007.10]
Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. [2007.10]
Safety and efficacy of botox injection in alleviating post-operative pain and improving quality of life in lower extremity limb lengthening and deformity correction. [2007.09.28]
Botulinum toxin A does not alter capsaicin-induced pain perception in human skin. [2007.09.15]
Botulinum toxin A adjunctive use in manual chemabrasion: controlled long-term study for treatment of upper perioral vertical wrinkles. [2007.09]
A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine. [2007.09]
Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence. [2007.09]
Kinematic aiming task: measuring functional changes in hand and arm movements after botulinum toxin-A injections in children with spastic hemiplegia. [2007.07]
Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin. [2007.07]
Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review. [2007.07]
Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial. [2007.07]
Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation. [2007.07]
Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. [2007.06]
Factors associated with the prophylactic effect of placebo injections in subjects enrolled in a study of botulinum toxin for migraine. [2007.06]
A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches. [2007.06]
Intragastric injection of botulinum toxin A for the treatment of obesity. [2007.06]
Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. [2007.05]
A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity. [2007.05]
Upper-limb botulinum toxin a injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial. [2007.05]
Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial. [2007.05]
Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. [2007.04]
Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. [2007.04]
Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials. [2007.04]
Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. [2007.04]
Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection. [2007.03]
Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. [2007.02.06]
Treatment of chronic radial epicondylitis with botulinum toxin a. A double-blind, placebo-controlled, randomized multicenter study. [2007.02]
UV-B irradiation attenuates dermal effects of botulinum toxin A: a randomized, double-blind, placebo-controlled study. [2007.01]
Making scents: improvement of olfactory profile after botulinum toxin-a treatment in healthy individuals. [2007.01]
Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial. [2007.01]
A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm. [2007.01]
Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction. [2007.01]
A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity. [2007.01]
Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy. [2007.01]
Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity. [2007]
The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial. [2006.12]
Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized study. [2006.12]
Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. [2006.12]
Efficacy of botulinum toxin type a after topical anesthesia. [2006.11]
Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity? [2006.11]
Botulinum toxin vs. topical glyceryl trinitrate ointment for pain control in patients undergoing hemorrhoidectomy: a randomized trial. [2006.11]
Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. [2006.11]
Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia. [2006.10.31]
Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. [2006.10]
A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis. [2006.10]
Efficacy and safety of botulinum toxin a injection compared with topical nitroglycerin ointment for the treatment of chronic anal fissure: a prospective randomized study. [2006.09]
Botulinum toxin to improve facial wound healing: A prospective, blinded, placebo-controlled study. [2006.08]
Frozen versus fresh reconstituted botox for laryngeal dystonia. [2006.08]
A double-blind, controlled study of botulinum toxin A in chronic myofascial pain. [2006.07.25]
Comparison of the efficacies of botulinum toxin A and Johnstone pressure splints against hip adductor spasticity among patients with cerebral palsy: a randomized trial. [2006.07]
|
